Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

March 2, 2022

Study Completion Date

December 19, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

iRF System Hepatic Denervation

The iRF System is a percutaneous, catheter-based device which uses RF energy to circumferentially denervate the sympathetic nerves surrounding the common hepatic artery (CHA).

Trial Locations (8)

17011

UPMC Pinnacle, Harrisburg

32804

AdventHealth Translational Research Institute, Orlando

35211

Cardiology, P.C., Birmingham

55433

Metropolitan Cardiology Consultants, Coon Rapids

62701

Prairie Education & Research Cooperative (PERC), Springfield

73135

South Oklahoma Heart Research, LLC, Oklahoma City

75226

Soltero Cardiovascular Research Center, Dallas

94305

Stanford University Medical Center, Stanford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Metavention

INDUSTRY

NCT04285554 - Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects | Biotech Hunter | Biotech Hunter